Literature DB >> 23526148

Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE).

Mengya Zhu1, Hanyou Mo, Dong Li, Xiaohong Luo, Lihua Zhang.   

Abstract

The objective of the study was to investigate whether the immunological factors in patients with Systemic Lupus Erythematosus (SLE) and a high incidence of atherosclerosis correlate with a Th17/Treg imbalance. All cases were recruited from the Affiliated Hospital of Guilin Medical University: a random sample of 42 cases with SLE and atherosclerosis, 39 positive control cases with SLE alone with no anomalies detected via coronary artery angiography or carotid color Doppler ultrasound examination, as well as 45 normal controls based on physical examination were included. The serum expression levels of IL-10, IL-17, IL-6, TNF-α, Th17, Th17 cell transcription factor RORγt, and Treg cell transcription factor Foxp3 were measured in each group of patients. Correlations among Th17/Treg, their secreted cell factors, transcription factors, SLE, and SLE with concurrent atherosclerosis (SLE + AS) were analyzed. The results are as follows: (1) total cholesterol and triacylglycerol levels in the SLE and SLE + AS groups were higher than those in the control group (P < 0.05 and P < 0.01); (2) serum IL-10 in the SLE + AS group was lower than the SLE and control groups; however, serum IL-17 and IL-6 levels in the SLE + AS group were elevated compared to the SLE and control groups (average P < 0.01); (3) the percentage of Treg cells in the SLE + AS patients was lower than those found in the SLE and control groups; in contrast, percentages of serum Th17 cells in SLE + AS patients were higher than the SLE and control groups (average P < 0.01); (4) FoxP3 expression in the SLE + AS group was lower than levels observed in the SLE and control groups (average P < 0.05); in contrast, RORγt expression in the SLE + AS group was higher than levels found in the SLE and control groups (average P < 0.05). The abnormal balance between Th17 cells and Treg cells in SLE + AS patients has obvious implications for Th17 migration. The results suggest that Th17 cell proportion and function can be enhanced, relatively or absolutely, whereas the proportion and function of Treg cells can abate, relatively or absolutely. This imbalance may be an important reason for the high incidence of SLE with atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526148     DOI: 10.1007/s10067-013-2237-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Authors:  Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

2.  Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

Authors:  Israel Gotsman; Nir Grabie; Rajat Gupta; Rosa Dacosta; Malcolm MacConmara; James Lederer; Galina Sukhova; Joseph L Witztum; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

Review 3.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Lupus Atherosclerosis Prevention Study (LAPS).

Authors:  M A Petri; A N Kiani; W Post; L Christopher-Stine; L S Magder
Journal:  Ann Rheum Dis       Date:  2010-12-21       Impact factor: 19.103

6.  Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study.

Authors:  P E Puddu; M Lanti; A Menotti; M Mancini; A Zanchetti; M Cirillo; M Angeletti; W Panarelli
Journal:  Acta Cardiol       Date:  2001-08       Impact factor: 1.718

7.  Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Wendy S Post; Laurence S Magder; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2011-08-28       Impact factor: 7.580

Review 8.  The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity.

Authors:  N S Wade; A S Major
Journal:  Thromb Haemost       Date:  2011-10-06       Impact factor: 5.249

9.  Cardiovascular risk and lupus disease.

Authors:  M Boucelma; F Haddoum; H Chaudet; G Kaplanski; N Mazouni-Brahimi; A Rezig-Ladjouze; M Brouri; A Berrah
Journal:  Int Angiol       Date:  2011-02       Impact factor: 2.789

10.  Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis.

Authors:  Qian Xing; Bin Wang; Houheng Su; Jiajia Cui; Jinghua Li
Journal:  Rheumatol Int       Date:  2011-01-18       Impact factor: 2.631

View more
  24 in total

1.  Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.

Authors:  Bingjie Shui; Weibiao Xia; Chengping Wen; Xinghong Ding
Journal:  J Nat Med       Date:  2015-03-28       Impact factor: 2.343

2.  IL-33 neutralization suppresses lupus disease in lupus-prone mice.

Authors:  Pin Li; Wei Lin; Xiangxiong Zheng
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.

Authors:  Warren Raymond; Gro Ostli-Eilertsen; Sheynae Griffiths; Johannes Nossent
Journal:  Eur J Rheumatol       Date:  2017-03-01

Review 4.  The T helper type 17/regulatory T cell paradigm in pregnancy.

Authors:  Ana Sofia Figueiredo; Anne Schumacher
Journal:  Immunology       Date:  2016-05       Impact factor: 7.397

5.  Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.

Authors:  Xiao Hu; Yahong Wang; Ling-Yang Hao; Xikui Liu; Chuck A Lesch; Brian M Sanchez; Jay M Wendling; Rodney W Morgan; Tom D Aicher; Laura L Carter; Peter L Toogood; Gary D Glick
Journal:  Nat Chem Biol       Date:  2015-01-05       Impact factor: 15.040

6.  TRAF6 regulates the effects of polarized maturation of tolerability: Marrow-derived dendritic cells on collagen-induced arthritis in mice.

Authors:  Chenchen Zhuang; Xuezhi Hong; Jia Liu; Xiaohong Luo; Hanyou Mo
Journal:  Biomed Rep       Date:  2017-01-05

Review 7.  Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.

Authors:  Christopher B Oliveira; Mariana J Kaplan
Journal:  Semin Immunopathol       Date:  2022-03-30       Impact factor: 11.759

Review 8.  Cardiovascular disease in systemic lupus erythematosus.

Authors:  Maureen McMahon; Richard Seto; Brian J Skaggs
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

Review 9.  Atherosclerosis and multi-organ-associated pathologies.

Authors:  W Coles Keeter; Shelby Ma; Natalie Stahr; Alina K Moriarty; Elena V Galkina
Journal:  Semin Immunopathol       Date:  2022-03-03       Impact factor: 11.759

Review 10.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.